Search Within

Weinberg Fellows

  1. "Department of Medicine"
Formats
  1. Meeting Abstract (1345)
  2. Journal Article (1100)
  3. Review (120)
  4. Editorial (55)
  5. Research Letter (34)
  6. Correspondence (26)
  7. Book Section (24)
  8. Guidelines (12)
  9. Conference Paper (2)
  10. Miscellaneous (2)
Groups
  1. Department of Medicine (2720)
  2. Hematology-Oncology Fellows (2649)
  3. Solid Tumor Oncology Division (2011)
  4. Hematologic Malignancies, Division of (1333)
  5. GSK Faculty (1223)
  6. Department of Pathology and Laboratory Medicine (982)

More Groups

People
  1. Michael Berger (220)
  2. Marc Ladanyi (198)
  3. Pedram Razavi (184)
  4. Michael Offin (177)
  5. Sergio Giralt (171)
  6. David Solit (169)

More People

Years
  1. 2025 (206)
  2. 2024 (382)
  3. 2023 (306)
  4. 2022 (369)
  5. 2021 (334)
  6. 2020 (319)

More Years

Publications
  1. Journal of Clinical Oncology (547)
  2. Blood (294)
  3. Annals of Oncology (102)
  4. Clinical Cancer Research (97)
  5. Journal of Thoracic Oncology (93)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Clinical Oncology (616)
  2. Elsevier Inc. (337)
  3. American Society of Hematology (333)
  4. American Association for Cancer Research (235)
  5. Nature Publishing Group (197)
  6. Oxford University Press (151)

More Publishers

Results (2720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy and safety of cabozantinib (CABO) for advanced Grade 3 (G3) neuroendocrine tumours (NETs) after progression on prior therapy: Subgroup analysis of the phase III CABINET trial (Alliance A021602)
    Meeting Abstract

    Strosberg, J.; Zemla, T.; Geyer, S.; Pulsipher, S.; Behr, S.; Raj, N.; Vijayvergia, N.; Dasari, A.; Meyerhardt, J.; Wolin, E.; more...
    Journal of Neuroendocrinology (2025)

    Fulltext@MSK | Save
  • Pancreatic neuroendocrine tumours (pNET) and MUTYH germline (GPV) and somatic (SPV) pathogenic variants: A multinational study
    Meeting Abstract

    Riechelmann, R.; Torrezan, G. T.; Cingarlini, S.; Raj, N.; Bergsland, E.; Strosberg, J.; Trevisani, E.; Moon, F.; Felismino, T. C.; Knappskog, S.; more...
    Journal of Neuroendocrinology (2025)

    Fulltext@MSK | Save
  • Global-scale patient-partnered genomic databanking: unlocking therapeutic and biological insights in rare cancers through decentralized recruitment and open data sharing
    Meeting Abstract

    Doe-Tetteh, S. A.; Camp, S. Y.; Crowdis, J.; Noronha, A. M.; Alano, T.; Reales, D.; Viale, A.; Donoghue, M.; Socci, N. D.; Berger, M. F.; more...
    Cancer Epidemiology Biomarkers and Prevention (2025)

    Fulltext@MSK | Save
  • Health disparities among women who received treatment for 1L advanced and recurrent endometrial cancer in the United States
    Meeting Abstract

    McClain, K. M.; Prabhu, V. S.; Marupuru, S.; Meng, K.; Tran, V.; Woodhouse, K.; Meng, R.; Green, A. K.; Makker, V.
    Cancer Epidemiology Biomarkers and Prevention (2025)

    Fulltext@MSK | Save
  • Proton craniospinal irradiation for patients with leptomeningeal metastasis
    Journal Article

    Yang, J. T.; Yerramilli, D.; Pentsova, E.; Wolden, S.; Young, R. J.; Correa, D. D.; Imber, B. S.; Wijetunga, N. A.; Goglia, A. G.; Zhang, Z.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • ASO Visual Abstract: Clinicopathologic characteristics and clinical outcomes of patients with testicular mesothelioma
    Miscellaneous

    Agrawal, P.; Baky, F.; Sarungbam, J.; Sheinfeld, J.; Reuter, V. E.; Cercek, A.; Nash, G. M.; Sauter, J. L.; Travis, W. D.; Simone, C. B. 2nd; more...
    Annals of Surgical Oncology (2025)

    Fulltext@MSK | Save
  • A phase II trial of hepatic ablation of metastases to modulate and enhance immunotherapy response in non-small cell lung cancer (HAMMER-NSCLC)
    Journal Article

    McMillan, M. T.; Reyngold, M.; Crane, C. H.; O'Brien, D. A. R.; Williams, V. M.; Zinovoy, M.; Cuaron, J. J.; Gönen, M.; Kaiser, A.; Sopka, D. M.; more...
    BMC Cancer (2025)

    Fulltext@MSK | Save
  • Treatment outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg-type in the rituximab era
    Correspondence

    Cassanello, G.; Drill, E.; Qiu, A.; Ewalt, M. D.; Hamlin, P.; Horwitz, S. M.; Joffe, E.; Kumar, A.; Moskowitz, A. J.; Noy, A.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Real-world outcomes of neoadjuvant chemoimmunotherapy in patients with nonsmall cell lung cancer: Predictors of surgery, pathologic complete response, and event-free survival
    Journal Article

    Cooper, A. J.; Garbo, E.; Arfe, A.; Conroy, M.; Shaverdian, N.; Bott, M.; Gorria, T.; Pecci, F.; Aldea, M.; Anagnostou, V.; more...
    Cancer (2025)

    Fulltext@MSK | Save
  • Elevated circulating tumor cells reflect high proliferation and genomic complexity in multiple myeloma
    Journal Article

    Garces, J. J.; Diamond, B.; Sevcikova, T.; Nenarokov, S.; Bilek, D.; Radova, E.; Venglar, O.; Kapustova, V.; Firestone, R.; Maclachlan, K.; more...
    HemaSphere (2025)

    Fulltext@MSK | Save